IgA2 B cells and IgA2 anti-dsDNA antibodies are selectively targeted by belimumab after rituximab...
McCluskey et al. show that baseline serum IgA2 anti-dsDNA antibody levels are a companion biomarker of response to belimumab after rituximab in systemic lupus erythematosus. Increased BAFF receptor...
cell.com